Company intelligence / Profile preview

BioInteractions

Reading/Shinfield, Berkshire, United Kingdombiointeractions.com ↗

Ownership: Private
Employees: ~14
Development stage: Commercial

Overview

BioInteractions has developed and commercialized multiple advanced multi-action coating technologies for medical devices, including antithrombogenic, antimicrobial, and hydrophilic solutions. These have been adopted by OEMs globally to enhance device safety and performance.

Modalities: DevicePolymer-drug conjugate therapy (for drug-eluting coatings)
Industry: Chemicals & Materials

Drug pipeline

3 assets

AstutePlus

Commercial

Indications: Thrombosis prevention

2 more assets in the full pipeline.

Request access →

Partnerships

Major partnerships with original equipment manufacturers (OEMs) in the global medical device industry; specific partner names not disclosed publicly.

Beyond the preview

Go deeper on BioInteractions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioInteractions.

Explore the full profile